基于多糖的静血材料的近期研究进展:一篇综述
1Fujian Key Laboratory of Polymer Materials, College of Chemistry and Materials Science, Fujian Normal University, Fujian 350007, China.
International journal of biological macromolecules
|May 31, 2024
概括
多糖为严重出血提供安全有效的静血材料. 这些生物相容,可生物降解的药物对于开发先进的伤口护理解决方案至关重要.
科学领域:
- 生物材料科学 生物材料科学
- 医疗工程 医疗工程
- 聚合物化学 聚合物化学
背景情况:
- 由于创伤引起的大规模出血,需要快速静血材料.
- 目前的血静止剂面临的局限性包括生物相容性差,毒性和生物降解性.
- 多糖体具有卓越的生物相容性和体内可生物降解性.
研究的目的:
- 审查基于多糖的静血材料.
- 探索它们的形式,机制和应用.
- 讨论聚糖类血静止剂的未来机遇和挑战.
主要方法:
- 关于多糖类血静止剂的文献综述.
- 血液静止机制的分析.
- 临床应用和未来前景的评估.
主要成果:
- 像阿尔金酸盐 (AG) 和酸盐 (CS) 这样的多糖化合物显示出作为静血剂的前景.
- 它们的无毒降解产品可以被人体吸收.
- 显著的注意力是给出基于多糖的材料在血液静止.
结论:
- 多糖对于开发先进的,生物相容的血静性材料有价值.
- 进一步的研究可以克服挑战并扩大应用.
- 多糖血静止剂是体内血静止的一个有希望的领域.
相关概念视频
01:05Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675